Compare BARK & CYPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BARK | CYPH |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.7M | 73.3M |
| IPO Year | 2020 | 2019 |
| Metric | BARK | CYPH |
|---|---|---|
| Price | $7.77 | $2.53 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | 36.5K | ★ 13.0M |
| Earning Date | 11-09-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 103.87 |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $394,843,000.00 | $1,500,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.97 | $408.92 |
| P/E Ratio | $96.63 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.50 | $0.49 |
| 52 Week High | $11.32 | $4.19 |
| Indicator | BARK | CYPH |
|---|---|---|
| Relative Strength Index (RSI) | 35.63 | 46.25 |
| Support Level | $0.62 | $0.68 |
| Resistance Level | $9.86 | $3.23 |
| Average True Range (ATR) | 0.29 | 0.37 |
| MACD | 0.01 | -0.14 |
| Stochastic Oscillator | 23.89 | 10.58 |
BARK Inc believe that dogs and humans are good together and it aspire to be the world's favorite dog brand. It is a team of dog-obsessed people committed to delivering personalization at scale by satisfying each dog's distinct personality, preferences, and needs with the products and services. It is an omnichannel brand that designs and develops proprietary products for dogs across two key brands: BarkBox and Super Chewer. All of its products are designed and developed in-house, and are BARK branded. Its segments are DTC, and Commerce. It generates majority of revenue from DTC. Direct to Consumer generates revenue from subscription products that feature monthly themes of premium quality BarkBox and Super Chewer toys and BARK-branded treats and chews.
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.